A new cancer vaccine shows promise for treating a range of more aggressive HER2-positive cancers in an early, phase I clinical trial. Lesen Sie weiter auf: New cancer vaccine may tackle HER2-positive tumors Quelle: Medical News Today | Immune System / Vaccines Titelbild/Grafik by Medical News Today | Healthline Media UK Ltd.